Tag:
3M
Latest Headlines
Latest Headlines
Court: British gov't, Porton get $1.3M in 3M dispute
In a bizarre case that involved a supposedly ineffective MRSA test, the British Defense Ministry, the Porton Group, a private equity firm and Ploughshare Innovations Limited have won $1.3 million in
U.K. official admits he spoke briefly to Porton CEO about 3M battle
The strange battle between 3M and the Porton Group just got odder. Liam Fox, the U.K.'s defense secretary, is now backtracking on a claim that he never had any discussions about the legal battle with
Reports: British defense sec. could be subpoenaed in 3M case
Liam Fox, Britain's defense secretary, may be forced to give evidence in a blackmail trial involving 3M and the Porton Group in the U.S., the Guardian is reporting. If he is subpoenaed, Fox would be
Porton calls 3M suit 'false and reckless'
Attorneys for the investment group Porton and its CEO Harvey Boulter have described a complaint filed by 3M accusing the private equity firm of blackmail as a "false and reckless...publicity stunt
3M accuses Porton CEO of blackmail
3M is firing back at Porton Capital, a private equity firm, accusing its CEO Harvey Boulter of attempting to extort $30 million from the manufacturer to settle a lawsuit in the U.K. The company filed
Case against 3M opens in the U.K.
A case against 3M opened in a London court last week, with lawyers representing the U.K. government and the Porton Group, a private equity firm, alleging the multinational company breached its
Phosphagenics, 3M a step closer to oxycodone patch
Australia's Phosphagenics says it is a step closer to commercializing an oxycodone "pain patch" after reporting some success with its partner on the project, 3M Drug Delivery Systems. 3M has refined
Thulin tapped as 3M COO
3M has promoted one of three executives said to be in line to succeed CEO George Buckley. Inge Thulin has named to the new post of operations chief. Buckley's contract expires in February on his 65th
Private equity firm urges FDA to investigate 3M
Porton Group, a private equity group, wants the FDA to investigate whether 3M botched clinical trials on BacLite, a product for detecting MRSA in hospitals. The group is already suing the company in
3M, beleagured J&J, announce financial results
It's earnings time, and a number of big players have announced their Q4 and yearly results, including Johnson & Johnson ( $JNJ ) and 3M ( MMM ). And, perhaps not unexpectedly, pharma/device giant
